• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

播散性牛分枝杆菌感染:卡介苗免疫疗法的一种罕见并发症。

Disseminated Mycobacterium bovis Infection: A Rare Complication of Bacillus Calmette-Guérin Immunotherapy.

作者信息

Henriques Mendes Marina, Guimarães André, Dahlstedt Ferreira Catrine, Carneiro Fátima, Santos Lurdes

机构信息

Internal Medicine, Centro Hospitalar Tâmega e Sousa, Penafiel, PRT.

Infectious Diseases, Centro Hospitalar de São João, Porto, PRT.

出版信息

Cureus. 2023 Dec 12;15(12):e50407. doi: 10.7759/cureus.50407. eCollection 2023 Dec.

DOI:10.7759/cureus.50407
PMID:38094875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10716573/
Abstract

Intravesical instillation of bacillus Calmette-Guérin (BCG) is a crucial adjunctive therapy in the treatment of bladder carcinoma. Its systemic complications are rare but include disseminated () infections, the diagnosis of which is a challenging task that requires keen clinical awareness. We report the case of an adult male treated with BCG who presented with fever, nonspecific constitutional symptoms, hepatic cytolysis, and cholestasis. After a detailed workup, the diagnosis was made of disseminated infection with hepatic, pulmonary, renal, and ureteral involvement. Prompt anti-tuberculosis treatment resulted in clinical and analytical improvement. This case highlights the importance of early recognition of this serious complication in patients with BCG exposure, as well as the difficulty in confirming the diagnosis for proper treatment.

摘要

膀胱内灌注卡介苗(BCG)是膀胱癌治疗中的关键辅助疗法。其全身并发症罕见,但包括播散性()感染,对此类感染的诊断是一项具有挑战性的任务,需要敏锐的临床意识。我们报告一例接受卡介苗治疗的成年男性病例,该患者出现发热、非特异性全身症状、肝细胞溶解和胆汁淤积。经过详细检查,诊断为播散性感染,累及肝脏、肺、肾和输尿管。及时的抗结核治疗使临床和分析结果得到改善。该病例强调了早期识别卡介苗暴露患者中这种严重并发症的重要性,以及确诊以便进行适当治疗的困难。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ea/10716573/d03d4523afe5/cureus-0015-00000050407-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ea/10716573/16dbd996b6d5/cureus-0015-00000050407-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ea/10716573/564c94b9d267/cureus-0015-00000050407-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ea/10716573/be51136953a4/cureus-0015-00000050407-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ea/10716573/d03d4523afe5/cureus-0015-00000050407-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ea/10716573/16dbd996b6d5/cureus-0015-00000050407-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ea/10716573/564c94b9d267/cureus-0015-00000050407-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ea/10716573/be51136953a4/cureus-0015-00000050407-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ea/10716573/d03d4523afe5/cureus-0015-00000050407-i04.jpg

相似文献

1
Disseminated Mycobacterium bovis Infection: A Rare Complication of Bacillus Calmette-Guérin Immunotherapy.播散性牛分枝杆菌感染:卡介苗免疫疗法的一种罕见并发症。
Cureus. 2023 Dec 12;15(12):e50407. doi: 10.7759/cureus.50407. eCollection 2023 Dec.
2
Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement: A rare complication of BCG immunotherapy. A case report and narrative review.播散性卡介苗(BCG)感染累及肺和肾:BCG免疫疗法的一种罕见并发症。病例报告及文献综述
Pulmonology. 2020 Nov-Dec;26(6):346-352. doi: 10.1016/j.pulmoe.2019.10.001. Epub 2019 Nov 9.
3
Systemic Bacillus Calmette-Guérin (BCG) Infection With Renal Involvement: A Rare Complication of BCG Immunotherapy.系统性卡介苗(BCG)感染伴肾脏受累:BCG免疫治疗的一种罕见并发症。
Cureus. 2022 Dec 30;14(12):e33134. doi: 10.7759/cureus.33134. eCollection 2022 Dec.
4
Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder.播散性牛分枝杆菌感染并发膀胱内卡介苗灌注治疗浅表性膀胱移行细胞癌
Clin Med Insights Case Rep. 2016 Aug 16;9:71-3. doi: 10.4137/CCRep.S39904. eCollection 2016.
5
Disseminated infection due to Mycobacterium bovis after intravesical BCG instillation.膀胱内灌注卡介苗后牛分枝杆菌引起的播散性感染。
World J Clin Cases. 2014 Jul 16;2(7):301-3. doi: 10.12998/wjcc.v2.i7.301.
6
Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.膀胱内卡介苗免疫治疗尿路上皮癌并发播散性牛分枝杆菌感染的组织病理学
Int J Surg Pathol. 2015 May;23(3):189-95. doi: 10.1177/1066896914567332. Epub 2015 Jan 22.
7
Systemic Bacillus Calmette-Guérin (BCG) Infection and Accompanying Warm Autoimmune Haemolytic Anaemia Following Intravesical BCG Immunotherapy.膀胱内卡介苗免疫治疗后发生的全身性卡介苗感染及伴发的温抗体型自身免疫性溶血性贫血
Eur J Case Rep Intern Med. 2023 Aug 9;10(9):004009. doi: 10.12890/2023_004009. eCollection 2023.
8
Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.膀胱癌初次膀胱内灌注卡介苗后发生分枝杆菌血症和肉芽肿性肝炎。
Am J Gastroenterol. 1993 Jul;88(7):1112-5.
9
Mycotic vascular infections of large arteries with Mycobacterium bovis after intravesical bacillus Calmette-Guérin therapy: case report.卡介苗膀胱内灌注治疗后发生牛分枝杆菌所致的大动脉霉菌性血管感染:病例报告
J Vasc Surg. 1999 Feb;29(2):377-81. doi: 10.1016/s0741-5214(99)70391-5.
10
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.卡介苗(BCG)膀胱内灌注作为膀胱癌辅助治疗后的感染:单中心系列研究中的发病率、危险因素及结局,并对文献进行综述
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.

本文引用的文献

1
Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice.在标准临床实践中,不同卡介苗菌株治疗膀胱肿瘤的安全性和有效性。
Actas Urol Esp (Engl Ed). 2018 May;42(4):238-248. doi: 10.1016/j.acuro.2017.10.003. Epub 2017 Dec 30.
2
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.卡介苗(BCG)膀胱内灌注作为膀胱癌辅助治疗后的感染:单中心系列研究中的发病率、危险因素及结局,并对文献进行综述
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.
3
Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG.
卡介苗(BCG)治疗中高危 Ta、T1 期膀胱乳头状癌的副作用:EORTC 泌尿生殖系统癌症组比较三分之一剂量与全剂量以及 1 年与 3 年维持 BCG 的随机 3 期研究结果。
Eur Urol. 2014 Jan;65(1):69-76. doi: 10.1016/j.eururo.2013.07.021. Epub 2013 Jul 24.
4
Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses.膀胱内治疗浅表性膀胱癌:随机试验和荟萃分析的系统评价。
Cancer Treat Rev. 2010 May;36(3):195-205. doi: 10.1016/j.ctrv.2009.12.005. Epub 2010 Jan 15.
5
Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.膀胱内灌注卡介苗能否降低浅表性膀胱癌患者的复发率?一项随机试验的荟萃分析。
Urology. 2006 Jun;67(6):1216-23. doi: 10.1016/j.urology.2005.12.014.
6
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.卡介苗维持免疫疗法用于复发性TA、T1期及原位膀胱移行细胞癌:西南肿瘤协作组的一项随机研究
J Urol. 2000 Apr;163(4):1124-9.